SEC Form 5 · accession 0001179110-17-008807
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maxine Gowen
Director
Period of report
Dec 31, 2016
Accepted (ET)
Jun 9, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 16, 2016 | G | 10,542 | $0.00 | A | 1 | D |
Table II — derivative securities
No Table II lines on this filing.